Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fleishaker

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pharmacology|February 24, 2001
Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteersJ C Fleishaker, K K Ryan, B J Carel, et al.
Psychopharmacology|January 1, 1991
Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetineT A Lasher, J C Fleishaker, R C Steenwyk, et al.
Journal of Clinical Pharmacology|April 1, 1997
Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationshipC E Wright, T L Sisson, J C Fleishaker, et al.
Journal of Clinical Pharmacology|June 1, 1989
Pharmacokinetics and pharmacodynamics of alprazolam following single and multiple oral doses of a sustained-release formulationJ C Fleishaker, J P Phillips, M G Eller, et al.
Pharmaceutical Research|December 1, 1991
In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylateJ W Skoug, M T Borin, J C Fleishaker, et al.
Cephalalgia : an International Journal of Headache|March 20, 2004
A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adultsJ R Baldwin, J C Fleishaker, N E Azie, et al.
Journal of Clinical Psychopharmacology|February 1, 1994
Relationship between concentrations of adinazolam and its primary metabolite in plasma and therapeutic/untoward effects in the treatment of panic disorderJ C Fleishaker, J H Greist, J W Jefferson, et al.
Journal of Clinical Pharmacology|February 1, 1993
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administrationJ C Fleishaker, G R Peters, K S Cathcart, et al.
Psychopharmacology|July 1, 1995
Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjectsJ C Fleishaker, P D Garzone, J H Chambers, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Biotransformation of tirilazad in human: 3. tirilazad A-ring reduction by human liver microsomal 5alpha-reductase type 1 and type 2L C Wienkers, R C Steenwyk, M J Hauer, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|February 24, 2001
Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteersJ C Fleishaker, K K Ryan, B J Carel, et al.
Psychopharmacology|January 1, 1991
Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetineT A Lasher, J C Fleishaker, R C Steenwyk, et al.
Journal of Clinical Pharmacology|April 1, 1997
Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationshipC E Wright, T L Sisson, J C Fleishaker, et al.
Journal of Clinical Pharmacology|June 1, 1989
Pharmacokinetics and pharmacodynamics of alprazolam following single and multiple oral doses of a sustained-release formulationJ C Fleishaker, J P Phillips, M G Eller, et al.
Pharmaceutical Research|December 1, 1991
In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylateJ W Skoug, M T Borin, J C Fleishaker, et al.
Cephalalgia : an International Journal of Headache|March 20, 2004
A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adultsJ R Baldwin, J C Fleishaker, N E Azie, et al.
Journal of Clinical Psychopharmacology|February 1, 1994
Relationship between concentrations of adinazolam and its primary metabolite in plasma and therapeutic/untoward effects in the treatment of panic disorderJ C Fleishaker, J H Greist, J W Jefferson, et al.
Journal of Clinical Pharmacology|February 1, 1993
Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administrationJ C Fleishaker, G R Peters, K S Cathcart, et al.
Psychopharmacology|July 1, 1995
Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjectsJ C Fleishaker, P D Garzone, J H Chambers, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Biotransformation of tirilazad in human: 3. tirilazad A-ring reduction by human liver microsomal 5alpha-reductase type 1 and type 2L C Wienkers, R C Steenwyk, M J Hauer, et al.
Pageof 8